The Types segment classifies the market by functional architecture and reagent chemistry, encompassing automated hematology analyzers, semi‑automated systems, benchtop units, high‑throughput platforms, and reagent kits. Automated analyzers, which integrate sample handling, measurement, and data management, generate the largest revenue share (approximately 45 %) because they meet the throughput requirements of large hospitals and reference labs. Semi‑automated instruments, contributing about 20 % of sales, are favored by medium‑size facilities that require manual oversight for quality control while still benefiting from partial automation. Benchtop analyzers, with an estimated 15 % share, address space‑constrained environments such as outpatient clinics and small laboratories, offering a balance between performance and footprint. High‑throughput platforms, responsible for roughly 10 % of the market, are deployed in national testing networks where processing of thousands of samples per day is routine. Finally, reagent kits—covering standard CBC reagents, specialized differential stains, and emerging molecular‑cell markers—account for the remaining 10 % and are priced according to assay complexity and reagent stability. Together, these type categories delineate the market taxonomy and drive investment decisions across the Hematology Analyzers & Reagents market.
